Meeting
2021 ASCO Annual Meeting
Pan-cancer evaluation of homologous repair deficiency somatic mutations and response to first-line anti-neoplastic therapy.
Authors
Jessica A Lavery
Memorial Sloan Kettering Cancer Center, New York, NY
Jessica A Lavery , Samantha Brown , Gregory J. Riely , Philippe L. Bedard , Ben Ho Park , Jeremy Lyle Warner , Kenneth L. Kehl , Eva M Lepisto , Hira Rizvi , Michele LeNoue-Newton , Caroline G. McCarthy , Celeste Yu , Ritika Kundra , Brooke Mastrogiacomo , Nikolaus Schultz , Julia Elizabeth Rudolph , Shawn Sweeney , Deborah Schrag , Katherine Panageas
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Prevention, Risk Reduction, and Hereditary Cancer
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Cancer Genetics
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 10535)
DOI
10.1200/JCO.2021.39.15_suppl.10535
Abstract #
10535
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
The spectrum of homologous recombination deficiency in cervical cancer: Is it also a cervical issue?
First Author: Muhammad Danyal Ahsan
Poster
2022 ASCO Annual Meeting
Detection of homologous recombination deficiency (HRD) in cell-free DNA (cfDNA) using an amplicon-based next-generation sequencing (NGS) assay.
First Author: Jonathan Poh
Poster
2023 ASCO Annual Meeting
Targeting germline or somatic DNA repair defects (beyond BRCA) in pancreatic cancer with niraparib: A phase II study (NIRA-PANC).
First Author: Anup Kasi
Poster
2023 ASCO Annual Meeting
Chemotherapeutic sensitivity in colorectal cancer expressing low RNA of wild type homologous recombination genes.
First Author: Daniel Walden